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Background: To examine human microRNA expression in fertile men and subsequently to compare expression
patterns of miRNAs in fertile and infertile men, specifically men with Sertoli Cell Only (SCO) histopathology.
Methods: Testicular tissues from men with azoospermia and SCO, as well as those of men with normal
spermatogenesis, were analyzed. MicroRNA was isolated using the miRCURY™ RNA Purification Kit. A miRCURY
LNA™ Universal RT system was used for detection of microRNA by quantitative real-time PCR. MicroRNA localization
was performed by in situ hybridizations (ISH) on formalin-fixed paraffin embedded (FFPE) tissue utilizing miRCURY
LNA™ microRNA ISH technology. Statistical analysis was performed by GenEx V5.0.
Results: MicroRNA expression was determined for 13 normal fertile men and 5 men with the confirmed diagnosis
of diffuse SCO. MiR-202-5p expression was reduced by 17-fold (P < 0.00001) in tissue from SCO men compared to
normal. MiR-34c-5p was reduced by 346-fold (P < 0.00001), miR-10b was reduced 18-fold (P < 0.00001), miR-191 was
reduced 20-fold (P = 0.001) and miR-126 was reduced 40-fold (P < 0.00001)) in tissues from SCO compared to
normal fertile men. Using ISH, miR-202-5p was localized to Sertoli cells of men with normal spermatogenesis, but
not in the Sertoli cells of men with SCO.
Conclusion: Number of miRNAs are differentially expressed in normal fertile men compared to men with SCO.
MicroRNA-202-5p is localized to Sertoli cells and its expression dramatically differs between fertile men and men
whose germ cells are depleted, suggesting a novel interaction for regulating microRNA expression between the
somatic and germ cell components of the seminiferous epithelium.
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Objectifs: Evaluer l’expression des microARN chez des hommes féconds puis comparer les profils d’expression de
ces miRNAs chez des hommes féconds et des inféconds qui présentent plus particulièrement un syndrome de
Sertoli seules (SCO) à l’histologie testiculaire.
Matériel et Méthodes: Ont été analysés des tissues testiculaires d’hommes avec azoospermie et SCO ainsi que
ceux d’hommes avec spermatogenèse normale. Les miRNAs ont été isolés avec la trousse de Purification miRCURY™
RNA. Le système miRCURY LNA™ Universal RT a été utilisé pour la détection quantitative de miARNs par PCR en
temps réel. La localisation des miARNs a été réalisée par hybridation in situ (HIS) sur des tissus fixés au formol et
inclus en paraffine en utilisant la technologie miRCURY LNA™ microRNA ISH. Les analyses statistiques ont été faites
avec GenEx V5.0.
Résultats: L’expression des microARNs a été faite chez 13 hommes féconds et 5 hommes avec un diagnostic
confirmé de SCO diffus. L’expression de miR-202-5p est réduite d’un facteur 17 (P < 0.00001) dans le tissu des
hommes SCO par rapport au tissu des hommes à spermatogenèse normale. L’expression de miR-34c-5p est réduite
d’un facteur 346 (P < 0.00001), celle de miR-10b d’un facteur 18 (P < 0.00001), celle de miR-191 d’un facteur 20
(P = 0.001) et celle de miR-126 d’un facteur 40 (P < 0.00001) dans les tissus des hommes SCO comparés à ceux des
hommes à spermatogenèse normale. MiR-202-5p a été localisé par HIS dans les cellules de Sertoli des hommes à
spermatogenèse normale, mais pas dans les cellules de Sertoli des hommes SCO.
Conclusions: Nombre de miARNs sont exprimés différentiellement chez les hommes féconds par rapport aux
hommes SCO. MicroARN-202-5p est localisé dans les cellules de Sertoli et son expression diffère de façon marquée
entre les hommes féconds et ceux dont les cellules germinales sont absentes; ceci suggère une nouvelle interaction –
entre les cellules somatiques et germinales constitutives de l’épithélium séminifère – impliquée dans la régulation de
l’expression des microARNs.
Mots-clés: microARN, Spermatogenèse, Infécondité masculine, miR-202-5p, Cellules de SertoliBackground
Infertility affects 10%–15% of couples worldwide (WHO,
1983) [1]. Half of all infertility cases are due to male fac-
tors, and about 60–75% of male infertility is idiopathic.
Most “idiopathic” male infertility is thought to be caused
by yet-to-be-identified genetic defects [2]. Spermatogen-
esis is a multistep complex process that displays strictly
a regulated spatiotemporal gene expression, and during
certain aspects of germ cell division, mRNA translation
is significantly repressed [3]. Studies have indicated that
microRNAs (miRNAs) may play a role in translational re-
pression during spermatogenesis [4]. Therefore the de-
regulation of miRNAs could play an essential role in
spermatogenic dysfunction.
miRNAs are 20 to 30 nucleotide noncoding single
strand RNA molecules that act to regulate mRNA stabil-
ity, and translation. They interact with their mRNA tar-
get through base-pairing, generally in their 3’UTR [5].
miRNAs appear to be evolutionarily conserved and play
critical roles in a variety of biological processes in differ-
ent cell types. Some miRNA show a tissue-specific ex-
pression, and several experiments have confirmed their
importance in regulating cellular growth and differentiation
[5,6]. Moreover, the overexpression of a tissue-specific
miRNA in nonrelated cells shifts its transcriptome toward
that of the lineage expressing the miRNA, making them a
possible target for therapeutic use [7].The majority of published literature on miRNAs focuses
on the role they play in biological processes, including cell
proliferation, differentiation, cell growth, death, and resist-
ance to stress [8,9]. Differences in expression profiles of
miRNAs have been linked to cancer, heart disease and
male infertility [10-13]. However, despite intensive investi-
gations, the cell type specificity of miRNA expression re-
mains poorly understood. In this study we quantitatively
examined miRNAs expression in normal human testis
and in men with a severe form of infertility: azoosper-
mia associated with Sertoli Cell Only (SCO) syndrome.
We also localized miRNAs of interest in testicular tis-




Weill Cornell Medical College Institutional review board
approval was obtained for this study. Testicular tissue for
SCO were obtained from male infertility patients during
therapeutically necessary procedures and were snap frozen
at the time of procurement, or sent to create formalin-
fixed paraffin-embedded (FFPE) sections. These men were
azoospermic, had Sertoli cell-only documented on testis
biopsy, and they had SCO documented in all dissected re-
gions of the testis using a microsurgical approach for testis
evaluation as part of a therapeutic attempt at sperm
Table 1 miRNA’s names, target sequences and catalog
numbers
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with obstructive azoospermia as well as from testes of
organ donors utilizing an approved procurement protocol.
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.
RNA isolation
Total RNA was isolated from testicular tissue using the
miRCURY™ RNA Isolation Kit (Cat No. 300111, Exiqon
Inc. Vedbaek, Denmark). It is based on spin column
chromatography using a proprietary resin as the separ-
ation matrix. This method of purification of total RNA
allows for the isolation of the very small (<200 nucleo-
tide) RNA fraction.
In brief, the frozen tissue is completely homogenized in
a lysis solution using TissueRuptor. The lysate is incubated
with Proteinase K for protein removal and loaded on a
spin column. The removal of genomic DNA is performed
directly on the column with DNase I (Qiagen, Venlo,
Limburg) at a final concentration of 0.25 Kunitz unit/μL.
Eluted total RNA was either used for cDNA synthesis or
stored in – 80° Celsius. RNA concentration was measured
with a fluorescence based quantitation assay using Qbit®
fluorometer (Life Technology™, NY, USA), and the integrity
of RNA was evaluated by calculating RNA integrity number
(RIN, based on the detection of 18S and 28S and the
amount of degradation products) on Agilent Bioanalyzer
2100 (Aligent Technologies, CA, USA). Only RNAs with
RIN greater to or equal to 7 were used in the expression
studies, this indicate that the RNA sample has minimal
degradation products.
Design of custom Pick-&-Mix testis specific miRNAs
panels
Nineteen miRNAs that had been previously reported to
be highly expressed in the testis were chosen to design a
custom made Pick and Mix testis specific miRNA hu-
man panel [14]. Additionally, 3 miRNAs (miR-103, miR-
191 and miR-423-5p) with stable expression in human
testis tissue were included to serve as reference miRNAs
in the expression analysis. Each plate is designed to
accept 22 × 4 samples in a pre-defined 96-well panel for-
mat to screen 4 different RNAs in one setting. Two wells
for each sample were used for inter-plate calibrator
(annotated as UniSp3 IPC) to aid with performing plate-
to-plate and run-to-run normalization analysis. The miR-
NAs panels were ordered and prepared from Exiqon Inc.
(Vedbaek, Denmark). miRNA names, target sequences
and their catalog numbers are listed in (Table 1).
cDNA synthesis and real-time qPCR
First strand of cDNA was synthesized using a Universal
cDNA Synthesis Kit II (Exiqon, Cat. No 203301). Anartificial RNA (kit based RNA spike-in) was added to
each reverse transcription reaction as a control to
confirm that the reverse transcription and amplification
occurred with equal efficiency in all samples. Twenty
nanogram of total RNA in 4 μL volume was mixed with
16 μL reverse transcriptase (RT) master mix containing
reaction buffer. Enzyme mix and spike-in were incu-
bated in a thermocycler at 42° Celsius for 60 min. RT
was then heat-inactivated at 95° Celsius for 5 min and
the reactions were cooled down and stored in – 20° Celsius.
Negative controls excluding template from the reverse
transcription reaction were included and profiled as for the
test samples.
The levels of miRNAs in whole testis samples was
measured using real-time PCR with custom Pick-and-
Mix testis-specific panels and SYBR® Green master mix
from Exiqon, (Cat No. 203450). Each plate was pre-
loaded with dried out miRNAs in all wells, cDNA from
each patient was diluted 1:100 and combined with 2×
SYBR® Green master (1:1). Samples and controls were
adjusted to 10 μL volume in all 24 wells. The amplifica-
tion reactions were performed on a LightCycler 480
Roche platform (Roche, IN, USA). The samples were
subjected to 95° Celsius denaturation for 10 min
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60° Celsius for 1 min with optical read at the end of
every cycle. Melting curve analysis was carried out to
check for examination of amplification products.
In Situ Hybridization (ISH)
To localize the differentially expressed miRNAs from
testicular tissues (to determine the cellular origin and
evaluate relative expression levels) ISH was performed
on FFPE sections. Double-Dig-labeled probe for miR-
202-5p (miRCURY LNA™ Detection probe, 5′-DIG and
3′-DIG labeled hsa-miR-202-5p, Exiqon, Cat No.
38814–15) was used. As a negative control, a scramble
probe was used (Probe No. 90–001). Additionally, as
positive control for testicular tissue, the has-miR-126
probe for endothelial cells was tested (Probe No. 90–
008). ISH was performed using manufacturers instruc-
tions. In brief, all FFPE sections were deparaffinized in
two washes of CitriSolve for 15 min and then hydrated
through sequentially increasing ethanol solutions. The
target demasking step was carried out in Proteinase K
solution at a concentration of 15 μg/mL at 37° Celsius
for 10 min. Following pre-digestion that allows the ac-
cess of double-DIG-labeled LNA™ probes to hybridize
to the miRNA sequence, sections were dehydrated in
gradual ethanol solutions and dried completely for
20 min. Probe, denatured at 90° Celsius for 4 min, was
diluted in 1x hybridization solution to a final concen-
tration of 40nM. A total of 50 μL was applied on each
slide. The slides were then covered with cover glass,
sealed with Fixogum and hybridized for 60 min. To
optimize performance for each probe and to ensure op-
timal signal to noise ratio, hybridization was performed
at a temperature of 30° Celsius below the probe melting
temperature. The slides were passed through stringent
washing steps of 5X, 1X and 0.2X SSC at hybridization
temperature. Digoxin was recognized by a sheep anti-
DIG-AP directly conjugated with the enzyme Alkaline
Phosphatase (AP) (Roche, Cat. No. 11 093 274 910).
The specimens were incubated for 60 min at room
temperature. AP converted the applied substrate NBT/
BCIP (Roche, Cat. No. 11 697 471 001) to the soluble
substrates 4-Nitro-Blue Tetrazolium (NBT) and 5-Bromo-
4-Chloro-3’-Indolylphosphate (BCIP) into a water and
alcohol insoluble dark-blue NBT-BCIP precipitate that
appears on slides after 2 h of incubation at 30° Celsius
in the dark. The reaction was stopped and slides were
counterstained with filtered Nuclear Fast Red™ (Vector
laboratories, Cat. No. H-3403). After washing in tap
water for 10 min and dehydration with ethanol, the
slides were mounted using Eukitt® mounting media
(VWR, Cat. No. 361894G). The slides were examined
by light microscopy the subsequent day and images
were obtained using Kodak microscope.Statistical analysis
Analysis of miRNA
The expression level of miRNAs was performed based on
absolute quantification analysis using second derivative
method by LightCycler 480 software from Roche allowing
Cp values to be calculated. GenEX software (MultiD
Analyses AB, Göteborg, Sweden) was used to analyze
and normalize the miRNA-qPCR data. This program
allows the correction of PCR efficiencies, the com-
pensation for differences between runs by normalizing
with interplate calibrators, and normalization with
endogenous reference genes. Data was normalized to
PCR efficiency (E), CpE ¼ 100% ¼ CpE log 1þEð Þlog2 , and for
differences between runs using Interplate normalisation




The Cp values of genes of interest were normalized to
plate average after removing Cp values that were greater
than 38. Normalisation of the gene of interest (GOI) to
reference Cp was done using the following formula:
CpGOI; norm ¼ CpGOI− 1n
Xn
i¼1
Cpavg . SCO was further
normalized to the relative expression of the same
miRNA in normal tissue to determine the fold changes
of differential expression in SCO tissue. The formula
for normalisation of SCO to normal tissues was the
RatioT/N = 2− CP(SCO) + Cp(Normal). The normality distri-
bution of the data was tested by the Kolmogorov-Smirnov
test. Parametric analysis (t-test according to Student with
paired and unpaired values) was used as appropriate. P-
values below 0.05 were regarded as statistically significant.Results
Expression of miRNA was determined for 13 normal fer-
tile men and 5 men with the confirmed diagnosis of diffuse
SCO using the 96 well plates of previously selected
primers that are relevant for testicular tissue. Mean age of
the cohort was 35(SD ± 6.7) years old. By applying an un-
paired two-tailed t-test for miRNAs that showed >2-fold
change in the considered groups, we found 8out of the 22
miRNA with significant differences in expression levels
when comparing the samples from SCO samples with the
normal testicular samples (P < .005). Detail of miRNA ex-
pression for SCO samples compared to normal are listed
in (Table 2). This is consistent with the fact that the great-
est changes detected in SCO/Normal miRNA comparisons
were for miR-34c-5p that was downregulated by a factor
of 346 (P < 0.00001). mir-34c-5p is believed to be predom-
inantly expressed in germ cells [10], reflecting the SCO
miRNA expression pattern in our samples. miR-126 was
downregulated by a factor of 40 (P < 0.00001), miR-126-5p
by a factor of 20.7, miR-191 by a factor of 20 (P = 0.001) in
Table 2 miRNA expression profiling in normal vs. SCO





















UniSp6 CP 1 0.34
hsa-miR-423-5p 1.5 0.11
hsa-miR-202 1.6 0.10
Figure 1 ISH of miR-202-5p, blue precipitate indicate cellular
expression of miRNA in normal testicular tissue, *normal
seminiferous tubules, scale 200 μm.
Figure 2 ISH of miR-202-5p, blue precipitate indicate cellular
expression of miRNA in normal testicular tissue, 1 spermatogonia,
2 primary spermatocyte, 3 Sertoli cell, 4 spermatid, scale 50 μm.
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5p expression was reduced by 17-fold (P < 0.00001) in
SCO men compared to normal. No significant increase in
miRNA expression levels was seen in men with SCO rela-
tive to normal testicular tissue levels.
To further decipher the expression profile in testicu-
lar tissue, and to determine the cell types that express
miR-202-5p, ISH was performed on both normal and
SCO testicular tissue. Hybridization signal specific for
of miR-202-5p was specifically detected in the Sertoli
cells of men with normal spermatogenesis (Figures 1, 2
and 3). The tissue of men with confirmed SCO had
no signal detectable for miR202-5p in Sertoli cells
(Figures 4 and 5). These observations reflect that miR-
202-5p are selectively expressed in Sertoli cells in men
with normal germ cells, but not in the Sertoli cells of
men with SCO. This localization pattern of miR-202-5P
is consistent with our qPCR results. There were no dif-
ferences in expression of control miRNAs between men
with normal spermatogenesis and SCO, using scramble
for negative control and miR-126 specific to endothelial
as a positive control.Discussion
Profiling of miRNA in human and murine testis has previ-
ously been reported in multiple published studies [14-16].
The testis specific expression of miRNAs in normal men
and men with clinical infertility have been corroborated by
these studies as well as the data in this manuscript. Several
miRNA clusters and their target genes as well as their
chromosomal origin have also been examined [14,15].
However, the cellular localization of specific testicular
miRNAs have not been well elucidated in human testicular
tissue. Since azoospermic men with failed spermatogenesis
have pathology ranging from Sertoli cell-only pattern to
maturation arrest, or hypospermatogenesis, analysis of the
cellular origins of these differentially expressed miRNAs is
important to better reflect their potential regulatory roles
in spermatogenesis and male infertility. In our study we
Figure 3 ISH of negative control in normal testicular tissue, 1
spermatogonia, 2 primary spermatocyte, 3 Sertoli cell, 4
spermatid, scale 50 μm.
Figure 5 ISH negative control in testicular tissue of men with
SCO, arrow Sertoli cells, scale 50 μm.
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viously shown to reveal cellular localization of mRNAs
and non-coding RNA [17].
Several of the testicular specific miRNAs identified in our
study have been evaluated by previous studies. However,
we identified eight novel miRNAs that have not been de-
tected previously and may play a role in testicular function
and spermatogenesis. We found that miR-204, miR-99b-
3p, miR-191, miR-509-3-5p, miR-99b, miR-10b, miR-126,
miR-126-5p, miR-103 are downregulated in samples from
men with SCO pathology pattern. We could only identify
three prior reports on the use of ISH to localize miRNA to
specific cell types in testes. ISH of the miR-34 family indi-
cated that miR-34b/c are primarily localized to sperma-
tocytes and spermatids in murine testicular tissue [15].
Whereas miR-34a appeared to be restricted to murine
spermatogonia residing on the basal membrane ofFigure 4 ISH miR-202-5p in testicular tissue of men with SCO,
arrow Sertoli cells, scale 50 μm.seminiferous tubules [18]. In another study, miR-383 was
highly expressed in primary spermatocyte and poorly
expressed in spermatids of samples of men with normal
spermatogenesis; whereas the expression of miR-383 in tis-
sues from men with severely impaired sperm production
was noticeably lower compared with the control group
[13]. Our study demonstrates that miR-202-5p is selectively
expressed in Sertoli cells in men with normal germ cells,
but not in the Sertoli cells of men with SCO.
To date, no direct physiological function for miR-202-
5p has been identified in humans. miR-202-5p/3p are a
member of the let-7 family. let-7 was the first human
miRNA to be discovered. let-7 and its family members
are highly conserved across species in sequence and
function. Deregulation of let-7 leads to a less differen-
tiated cellular state and the development of cell-based
diseases. In general high levels of let-7 expression is as-
sociated with cell differentiation and maturation [19].
miR-202-5p is expressed in Sertoli cells in the early XY
gonad [20]. Its expression was found to be downstream
of the testis-determining factor SOX9, that plays an im-
portant role in testicular development and maturation
[21]. Previous studies have suggested that miR-202 ex-
pression increases in testicular tissue postnatally and
during development, suggesting that the expression of
miR-202-5p is up-regulated in the testis at later develop-
mental stages [14]. These data indicate that miR-202-5p
expression is associated with male gonad development,
and its expression is restricted to Sertoli cells in the
adult testis.
The pathophysiology that leads to SCO pathology
pattern is not completely understood. It is debatable if
Sertoli cells did not develop normally so that germ cells
could not survive, or the function of Sertoli cells is nor-
mal, but SCO has arisen because of an inherent problem
with the germ cells. Sertoli cell dysfunction secondary to
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The absence of germ cells can result in de-differentiation
of Sertoli cells, so that Sertoli cell function reflects that of
immature Sertoli cells, leading to loss of expression of
miR-202-5p expression. Conversely, it is important to
recognize that the absence of germ cells may also be a re-
flection of underlying abnormalities in the Sertoli cells and
failure of their maturation [24]. During puberty, Sertoli
cells undergo a radical change in their morphology and
function, reflecting maturation from an immature prolifer-
ative state to a non-proliferative state [25]. This matur-
ation process is highly dependent on miRNAs, studies
have shown that Dicer-mutant Sertoli cells show a pro-
gressively aberrant development and loss of function [26].
The Sertoli cell maturation process switches on multiple
cell functions. Previous studies have suggested that miR-
202 expression increases in testicular tissue postnatally
and during development, indicating that the expression of
miR-202-5p is up regulated in the testis at later stages dur-
ing development [14]. Further rodent studies may help
elucidate whether loss of miR-202-5p is the cause or a
consequence of loss of germ cells in men with Sertoli Cell
Only syndrome.
Conclusion
Our results reveal several miRNAs that are differentially
expressed in normal fertile men compared to men with
SCO. miR-202-5p is highly expressed in Sertoli cells when
germ cells are present. This germ cell-dependent expres-
sion of miR-202-5p suggests a functional role of this
miRNA in Sertoli cell maturation and/or regulation of
spermatogenesis.
Abbreviation
SCO: Sertoli Cell Only; ISH: In Situ Hybridizations; FFPE: Formalin-Fixed
Paraffin Embedded; miRNAs: microRNAs; ISH: In Situ Hybridization.
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